Charles River Laboratories | CRL - 이자 수익

주가
180.56
매일 변경
1.25 0.70%
매월
18.81%
매년
73.20%
Q2 예상
170.85




이자 수익 변화 날짜
Agilent USD 17M 1000K 2025-09
Align Technology USD 3.25M 390K 2025-09
Bio-Rad Laboratories USD 13.7M 1000K 2025-09
Bruker USD 4.4M 1.5M 2025-09
Charles River Laboratories USD 1.1 1.1M 2025-09
Concord Medical Services Hldg CNY 5.8M 659K 2023-06
Danaher USD 1.27 8M 2025-09
Dentsply International USD 4M 1000K 2025-03
Galapagos EUR 12.56M 4.66M 2025-03
Illumina USD 0.98 10M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Intrexon USD 319K 602K 2024-06
IQVIA Holdings USD 13M 3M 2025-09
Merck EUR 27M 10M 2025-09
Pfizer USD 0.62 156M 2025-09
Quest Diagnostics USD 3M 1000K 2025-09
Revvity USD 0.4 8.34M 2025-09
Thermo Fisher Scientific USD 4.27 297M 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09
Veradigm USD 1.7M 1.6M 2022-09
Waters USD 2.5 4.51M 2025-09
West Pharmaceutical Services USD 4.7M 1.1M 2025-09